Back to SYRE

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC → SYRE

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
27
Latest value
$468K
Q3 2026
Peak value
$30.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$20K
Q4 2025$124K
Q4 2025$1.9M
Q1 2026$79K
Q1 2026$192K
Q1 2026$9.9M
Q1 2026$92K
Q1 2026$96K
Q1 2026$81K
Q2 2026$139K
Q2 2026$3.3M
Q2 2026$27.8M
Q2 2026$260K
Q2 2026$365K
Q2 2026$29K
Q2 2026$161K
Q2 2026$13.4M
Q2 2026$911K
Q3 2026$2M
Q3 2026$2.9M
Q3 2026$30.7M
Q3 2026$260K
Q3 2026$366K
Q3 2026$29K
Q3 2026$162K
Q3 2026$18.8M
Q3 2026$468K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$468K5.3K——
Q3 2026$18.8M210.8K——
Q3 2026$162K1.8K——
Q3 2026$29K327——
Q3 2026$366K4.1K——
Q3 2026$260K2.9K——
Q3 2026$30.7M344.8K——
Q3 2026$2.9M32.1K——
Q3 2026$2M22.4K——
Q2 2026$911K10.3K——
Q2 2026$13.4M150.8K——
Q2 2026$161K1.8K——
Q2 2026$29K327——
Q2 2026$365K4.1K——
Q2 2026$260K2.9K——
Q2 2026$27.8M313.4K——
Q2 2026$3.3M36.8K——
Q2 2026$139K1.6K——
Q1 2026$81K1.6K——
Q1 2026$96K1.9K——
Q1 2026$92K1.8K——
Q1 2026$9.9M196.6K——
Q1 2026$192K3.8K——
Q1 2026$79K1.6K——
Q4 2025$1.9M57.8K——
Q4 2025$124K3.8K——
Q4 2025$20K596——

Other funds holding SYRE

Other UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC positions

NVDA

NVIDIA CORPORATION

$14.5B
NVDA

NVIDIA CORPORATION

$13.7B
NVDA

NVIDIA CORPORATION

$13.1B
NVDA

NVIDIA CORPORATION

$12.8B
MSFT

MICROSOFT CORP

$12.5B
NVDA

NVIDIA CORPORATION

$12.1B
AAPL

APPLE INC

$11.2B
MSFT

MICROSOFT CORP

$10.1B